CVSA Stock Forecast & Price Target

Covista Inc. has demonstrated robust growth potential, with new undergraduate enrollment increasing by approximately 19% in 2009 and continuing positive trends as enrollments at Chamberlain and Walden institutions rose by 18% and 38%, respectively, from 2022 to 2025. The company's acquisition of Walden in 2020 has led to accelerated growth, evidenced by a double-digit year-over-year increase in applications, suggesting a positive trajectory for future enrollment and revenue generation. Additionally, EBITDA margins are expected to expand due to operating leverage from enrollment growth, providing a strong foundation for sustained financial performance even as new campus launches occur through FY29.

Covista Inc. has demonstrated a significant underperformance relative to the S&P 500 over the past six months, largely due to a decline in new student enrollments at its Chamberlain institution, which management has attributed to an ineffective marketing strategy. Additionally, the company's forward EV/EBITDA multiple has decreased dramatically from approximately 12x to 8.6x, indicating market skepticism regarding its growth prospects. Furthermore, the fundamental challenges within the post-secondary sector, compounded by stunted enrollment growth and increasing competition, suggest that Covista may struggle to recover future market share and maintain financial stability.